학술논문
ELRANATAMAB, A B-CELL MATURATION ANTIGEN-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM THE MAGNETISMM-3 STUDY
Document Type
Abstract
Author
Source
In Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S404-S405
Subject
Language
ISSN
2531-1379